Drug allergy project update

26 April 2017

The drug allergy scoping work is almost complete.

A report of the consultation undertaken to date has been submitted to the Australian Department of Health.

Engagement with key stakeholders such as the Australian Digital Health Agency will continue until the project completion in June 2017.

29 November 2016

In October, we met with key people from the Australian Digital Health Agency (ADHA), who manage My Health Record and many other digital health projects. We also met with key people from the Australian Commission for Safety and Quality in Health Care (ACSQHC), who are responsible for setting the standards for hospital accreditation.

The meeting was pivotal is assisting us to understand how My Health Record currently works and the Australian Digital Health Agency has agreed to prioritise working with the National Allergy Strategy on the allergy component of My Health Record.

There is still further consultation underway to engage with the states and territories to discuss current drug allergy management and e-health across Australia.

Learn more here: Standardising drug allergy management

Content updated 26 April 2017

National Allergy Strategy Rationale

Allergic diseases have become an increasingly important chronic disease and public health issue in Australia and other developed countries over the last two decades, contributing to increased demand for medical services, significant economic cost of care and reduced quality of life of people with allergic diseases and their carers.